Agaricus Blazei 1300 mg par jour
Food supplement declared in France, decision dated 10 June 2025
Agaricus Blazei 1300 mg par jour (Fair & Pure) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: leucine 60 mg per day. None of the rules we check flags an issue with its declared composition.
- Brand
- Fair & Pure
- Food business operator placing the product on the market
- GmbH
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 2 gélules par jour
- Intended populations
- General population
- Not recommended (according to the manufacturer)
- Breastfeeding women, Pregnant women
Declaration 328689, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Substances
| Name | Per day |
|---|---|
| leucine | 60 mg |
Additives
E460, E464
Other ingredients
Agaricus subrufescens Peck, huile de coton
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
Consommation pendant la grossesse et l'allaitement après consultation d'un médecin.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Brand : Fair & Pure
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Agaricus Blazei 1300 mg par jour (Fair & Pure): composition and regulation”, https://compoatlas.com/en/supplements/products/328689-agaricus-blazei-1300-mg-par-jour, updated 15 November 2026.